TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3034541

Group type: EXPERIMENTAL
Intervention: CMV hyperimmunoglobulin (CMV-Polyglobin) administered intravenously at 2 ml/kg bodyweight at three-week intervals up to day 105 after kidney transplantation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no infusions)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CMV hyperimmunoglobulin (CMV-Polyglobin) administered intravenously
Number of subjects: 100
Study: 2169833

Group type: EXPERIMENTAL
Intervention: +sotalol (400 mg every 12 h)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg every 12 h)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1097478

Group type: EXPERIMENTAL
Intervention: Penfluridol, administered in a dosage of 40 to 80 mg once a week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neuroleptics requiring daily administration
Number of subjects: 0
Study: 31655592

Group type: EXPERIMENTAL
Intervention: Night on call or overnight shift (Group A before night)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Night on call or overnight shift (Group A after night)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Night on call or overnight shift (Group B after night)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Night on call or overnight shift (Group B before night)
Number of subjects: 260
Study: 27139812

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation-induced blood flow
Number of subjects: 33

Group type: COMPARATOR
Intervention: Blood-flow restriction
Number of subjects: 33

Group type: COMPARATOR
Intervention: Passive rest
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 33
Study: 25805118

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) over 6 weeks plus routine care (RC)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Supportive Counselling (SC) plus routine care (RC)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Routine Care (RC) alone
Number of subjects: 308
Study: 24274342

Group type: EXPERIMENTAL
Intervention: Intra-arrest therapeutic hypothermia (IATH) using trans nasal evaporative cooling (TNEC) during CPR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment including therapeutic hypothermia initiated after hospital admission
Number of subjects: 0
Study: 21555501

Group type: EXPERIMENTAL
Intervention: CLON‐XR plus stimulant
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo plus stimulant
Number of subjects: 198
Study: 19002433

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Omega-3 EE90 (2 g/day)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study: 16672406

Group type: EXPERIMENTAL
Intervention: Pivmecillinam
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 14871280

Group type: EXPERIMENTAL
Intervention: Sequential therapy (rabeprazole 20 mg b.d. + amoxicillin 1 g b.d. for 5 days, followed by rabeprazole 20 mg b.d. + tinidazole 500 mg b.d. + clarithromycin 500 mg b.d. for 5 days)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Prolonged triple therapy (rabeprazole 20 mg b.d. + amoxicillin 1 g b.d. + clarithromycin 500 mg b.d. for 10 days)
Number of subjects: 96
Study: 11341166

Group type: EXPERIMENTAL
Intervention: Doxorubicin-docetaxel (DD)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Doxorubicin-cyclophosphamide (DC)
Number of subjects: 33
Study: 9109229

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy given preoperatively
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiation therapy and chemotherapy given preoperatively
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical resection
Number of subjects: 0
Study: 8197612

Group type: EXPERIMENTAL
Intervention: 2x 100 mg/day CsA from day 0
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: 2x 200 mg/day CsA from day 4
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: 2x 300 mg/day CsA from day 4
Number of subjects: 164
Study: 3070179

Group type: EXPERIMENTAL
Intervention: Intramuscular emulsified disulfiram (1 g in soybean emulsion)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Oral disulfiram
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Intramuscular emulsified disulfiram
Number of subjects: 5
Study: 31162810

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 80

Group type: COMPARATOR
Intervention: ADA guidelines diet
Number of subjects: 80
Study: 29516705

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.1 µg/kg/min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexmedetomidine (0.4 µg/kg/h)
Number of subjects: 0
Study: 28373674

Group type: EXPERIMENTAL
Intervention: Naltrexone/bupropion (NB)
Number of subjects: 2046

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2046
Study: 25048646

Group type: EXPERIMENTAL
Intervention: Nondrug, nonoperative interventions (e.g., weight loss, shoe orthoses)
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Nondrug, nonoperative interventions (e.g., strengthening exercises, stretching exercises)
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Nondrug, nonoperative interventions
Number of subjects: 591
Study: 24182579

Group type: EXPERIMENTAL
Intervention: Micro-osteoperforations
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no micro-osteoperforations)
Number of subjects: 20
Study: 21804624

Group type: EXPERIMENTAL
Intervention: Structured psychological intervention conducted by a nurse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine preparation for venipuncture (Control group)
Number of subjects: 0
Study: 19664895

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 668

Group type: COMPARATOR
Intervention: Control (no statin treatment)
Number of subjects: 668
Study: 16595583

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (LC) at a median dose of 1250 mg for 1 year
Number of subjects: 20

Group type: COMPARATOR
Intervention: Calcium carbonate (CC) during the whole study period (3 years)
Number of subjects: 20
Study: 15239415

Group type: EXPERIMENTAL
Intervention: Mismatched pairs (concrete/abstract)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Matched concrete pairs
Number of subjects: 56

Group type: COMPARATOR
Intervention: Matched abstract pairs
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: All three subset groups combined
Number of subjects: 56
Study: 11554654

Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 9042628

Group type: EXPERIMENTAL
Intervention: salmeterol 50 micrograms
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: salbutamol 200 micrograms
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study: 8181200

Group type: EXPERIMENTAL
Intervention: Erythropoietin (150 units/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (vehicle)
Number of subjects: 6
Study: 3370063

Group type: EXPERIMENTAL
Intervention: 20 mg i.v. over 1 h
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 20 mg p.o.
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 40 mg p.o.
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Renal clearance of metabolites
Number of subjects: 9
Study: 31521756

Group type: EXPERIMENTAL
Intervention: Partial peripheral neuromuscular blockade group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Free of neuromuscular blockade group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 29089192

Group type: EXPERIMENTAL
Intervention: Anti-staphylococcal vaccine
Number of subjects: 18688

Group type: COMPARATOR
Intervention: Control group (no vaccine)
Number of subjects: 18688
Study: 25837193

Group type: COMPARATOR
Intervention: Ropivacaine 0.186% (group R)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Ropivacaine plus 5 μg of sufentanil (group RS)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Bromage scale of motor block examination
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Onset time of sensory block
Number of subjects: 58
Study: 23216616

Group type: EXPERIMENTAL
Intervention: Low-hematocrit group (target hematocrit <45%)
Number of subjects: 365

Group type: COMPARATOR
Intervention: High-hematocrit group (target hematocrit 45 to 50%)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Low-hematocrit group
Number of subjects: 365

Group type: COMPARATOR
Intervention: High-hematocrit group
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 365
Study: 21315210

Group type: EXPERIMENTAL
Intervention: Fibrinolysis (FL)
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Primary percutaneous coronary intervention (PCI)
Number of subjects: 1168

Group type: EXPERIMENTAL
Intervention: Both FL and PCI
Number of subjects: 1168
Study: 19589258

Group type: EXPERIMENTAL
Intervention: Alternate-protocol group
Number of subjects: 115

Group type: COMPARATOR
Intervention: Traditional-protocol group
Number of subjects: 115
Study: 16544586

Group type: EXPERIMENTAL
Intervention: Cluster up-dosing scheme (3 weeks duration, 19 patients)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Traditional up-dosing scheme (13 weeks duration, 19 patients)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cluster up-dosing scheme
Number of subjects: 38

Group type: COMPARATOR
Intervention: Traditional up-dosing scheme
Number of subjects: 38
Study: 12727580

Group type: EXPERIMENTAL
Intervention: Genistein (54 mg/d)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Estrogen/progestin therapy (17beta-estradiol [1 mg/d] combined with norethisterone acetate [0.5 mg/d])
Number of subjects: 79
Study: 11078489

Group type: EXPERIMENTAL
Intervention: Quality-of-life scores after relapse
Number of subjects: 2000
Study: 9367464

Group type: EXPERIMENTAL
Intervention: Budesonide, 1,000 microg bid for 4 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 1342877

Group type: EXPERIMENTAL
Intervention: Topical acetylsalicylic acid (ASA) eye drops (1% solution), applied as one drop in each eye four times a day (q.i.d.) for 14 days.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo eye drops, applied as one drop in each eye q.i.d. for 14 days.
Number of subjects: 0
Study: 2856903

Group type: EXPERIMENTAL
Intervention: Oxmetidine, 600 mg bedtime
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 31246796

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (266 mg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional bupivacaine (75 mg)
Number of subjects: 44
Study: 30236824

Group type: EXPERIMENTAL
Intervention: mtDNA haplogroup M8*
Number of subjects: 628

Group type: EXPERIMENTAL
Intervention: m.8684C>T (marker for hg M8a)
Number of subjects: 628

Group type: COMPARATOR
Intervention: Total antioxidant capacity
Number of subjects: 628
Study: 26099760

Group type: EXPERIMENTAL
Intervention: aScope 2
Number of subjects: 60

Group type: COMPARATOR
Intervention: Karl Storz fibrescope
Number of subjects: 60
Study: 23895239

Group type: EXPERIMENTAL
Intervention: Test of Everyday Attention (TEA) forms AB, BC, CA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Reliable Change Index corrected for practice effect (RCIp)
Number of subjects: 90
Study: 21251705

Group type: EXPERIMENTAL
Intervention: Active compression-decompression CPR with augmented negative intrathoracic pressure
Number of subjects: 2470

Group type: COMPARATOR
Intervention: Standard CPR (control)
Number of subjects: 2470
Study: 17940544

Group type: EXPERIMENTAL
Intervention: Vitamin A+beta-carotene (VA+BC)
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Multivitamins (MV)
Number of subjects: 626
Study: 17684364

Group type: EXPERIMENTAL
Intervention: Geranylgeranylacetone (GGA) 150 mg/day for 2 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DIC 75 mg/day plus GGA 150 mg/day for 2 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: DIC 75 mg/day plus placebo (lactose 1.5 g/day) for 2 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (lactose 1.5 g/day) for 2 weeks
Number of subjects: 40
Study: 15293423

Group type: EXPERIMENTAL
Intervention: Prime & Bond NT, Dentsply/Caulk (2 coats and one cure)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Single Bond, 3M Espe (2 coats and one cure)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Prime & Bond NT, Dentsply/Caulk (2 coats and 2 cures)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Single Bond, 3M Espe (2 coats and 2 cures)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Prime & Bond NT, Dentsply/Caulk (one coat with B1 flowable resin)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Single Bond, 3M Espe (one coat with B1 flowable resin)
Number of subjects: 60
Study: 12055417

Group type: EXPERIMENTAL
Intervention: Normotensives without a family history of hypertension
Number of subjects: 212

Group type: COMPARATOR
Intervention: Untreated and uncontrolled hypertensives
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Treated and controlled hypertensives
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Normotensives with a family history of hypertension
Number of subjects: 212
Study: 9641712

Group type: EXPERIMENTAL
Intervention: Group well-child care (GWCC)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Individual well-child care (IWCC)
Number of subjects: 213
Study: 9715718

Group type: EXPERIMENTAL
Intervention: Asymptomatic carotid surgery trial (ACST) intervention
Number of subjects: 1657

Group type: COMPARATOR
Intervention: Doppler ultrasound evaluation
Number of subjects: 1657

Group type: COMPARATOR
Intervention: Data collection methods
Number of subjects: 1657

Group type: EXPERIMENTAL
Intervention: Continued recruitment in ACST
Number of subjects: 1657
Study: 1914803

Group type: EXPERIMENTAL
Intervention: Computerized method (Food-meter)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional method (diary)
Number of subjects: 21
Study: 6136745

Group type: EXPERIMENTAL
Intervention: dynamically oriented individual psychotherapy (10 hour-long sessions over 3 months)
Number of subjects: 101

Group type: COMPARATOR
Intervention: medical treatment
Number of subjects: 101
Study: 31640705

Group type: EXPERIMENTAL
Intervention: EQW + SGLT2i
Number of subjects: 1147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1147

Group type: COMPARATOR
Intervention: EQW
Number of subjects: 1147
Study: 29526281

Group type: EXPERIMENTAL
Intervention: Counseling
Number of subjects: 459

Group type: COMPARATOR
Intervention: No Counseling
Number of subjects: 459
Study: 26959184

Group type: EXPERIMENTAL
Intervention: PF-05231023
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25464680

Group type: EXPERIMENTAL
Intervention: Electro acupuncture therapy (10 sittings over 30 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional drug therapy (oral flunarizine 20 mg OD and paracetamol 500 mg SOS for 30 days)
Number of subjects: 60
Study: 23155310

Group type: EXPERIMENTAL
Intervention: Suture dragging combined with pad compression (SDPC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fistulotomy (FSLT)
Number of subjects: 60
Study: 20387411

Group type: EXPERIMENTAL
Intervention: Precocious eating/digestion
Number of subjects: 0
Study: 18972594

Group type: EXPERIMENTAL
Intervention: Etodolac
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nimesulid
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Naproxen sodium
Number of subjects: 30
Study: 15616030

Group type: EXPERIMENTAL
Intervention: Vitamin E (1,800 IU daily)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 12611732

Group type: EXPERIMENTAL
Intervention: Phospholipid-coated extracorporeal circulation (ECC) materials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noncoated ECC materials (Control)
Number of subjects: 0
Study: 9650124

Group type: EXPERIMENTAL
Intervention: Theophylline (165 mg)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 58
Study: 7775563

Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Crystalloid cardioplegia (Group B)
Number of subjects: 100
Study: 3378856

Group type: EXPERIMENTAL
Intervention: Tizanidine 3 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tizanidine 6 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diazepam 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29227845

Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) during 12-session exposure-based group CBT
Number of subjects: 169

Group type: COMPARATOR
Intervention: Pill placebo during 12-session exposure-based group CBT
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 169
Study: 29129190

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) protocol for AUD, sessions five and six of a 12-session protocol
Number of subjects: 146
Study: 24569031

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone marrow-derived cells (BMCs)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 204
Study: 23362832

Group type: EXPERIMENTAL
Intervention: Acute hypoxic (HY: FI O2 0.13)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Normoxic (NM: FI O2 0.21)
Number of subjects: 14
Study: 20659185

Group type: EXPERIMENTAL
Intervention: Microcrystalline cellulose membrane (Veloderm) applied every 5-10 days for 1 month after surgical debridement
Number of subjects: 55
Study: 18825145

Group type: EXPERIMENTAL
Intervention: Hypnotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relaxation therapy or multimodal therapy (combination of relaxation therapy, education, and psychotherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mindfulness meditation
Number of subjects: 0
Study: 17261891

Group type: EXPERIMENTAL
Intervention: Blueberin (300 mg, 3 times per day for 4 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 13129472

Group type: EXPERIMENTAL
Intervention: Capsaicin (135 mg capsaicin/d)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 10452228

Group type: EXPERIMENTAL
Intervention: Carbohydrate drinks (CHO)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Carbohydrate drinks with BCAA (CHO+BCAA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Flavored water placebo (P)
Number of subjects: 8
Study: 9033699

Group type: EXPERIMENTAL
Intervention: Rilmenidine (1 mg once or twice a day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Captopril (50 to 100 mg per day, in 2 divided doses)
Number of subjects: 51
Study: 1349757

Group type: EXPERIMENTAL
Intervention: Fluspirilene (1.5 mg per week)
Number of subjects: 1261

Group type: EXPERIMENTAL
Intervention: Fluspirilene (0.5, 1.0, or 1.5 mg per week)
Number of subjects: 1261

Group type: COMPARATOR
Intervention: Fluspirilene (max 1.5 mg/week)
Number of subjects: 1261
Study: 4047153

Group type: EXPERIMENTAL
Intervention: Periodic breast cancer screening
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Other screening modalities
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Screening maintenance
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 1000
Study: 29511047

Group type: EXPERIMENTAL
Intervention: IdeS-cleavage of IgG in samples from local IgG poor microenvironments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 27181277

Group type: EXPERIMENTAL
Intervention: Intensive therapy group (IT group; n = 22) - combined moderate intensity aerobic and resistance training three times per week for 12 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional therapy group (CT group; n = 20) - metformin and diet control
Number of subjects: 42
Study: 23334213

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 110
Study: 22430976

Group type: EXPERIMENTAL
Intervention: Single oral dose of ferroquine (400 to 1200 mg)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Repeated oral dose of ferroquine (400 to 800 mg over 3 days)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Single administration of 100 mg of ferroquine
Number of subjects: 82
Study: 19949779

Group type: EXPERIMENTAL
Intervention: Turning rate controlled using a steering wheel and speed controlled using a foot pedal.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison across groups with different maximum speed capabilities.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjects recalibrating to changes in maximum speed.
Number of subjects: 0
Study: 18633048

Group type: EXPERIMENTAL
Intervention: parecoxib 20 mg bid
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: parecoxib 20 mg qd
Number of subjects: 479

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 479
Study: 16158793

Group type: EXPERIMENTAL
Intervention: Double-layered heat- and pressure-laminated EVA mouthguard
Number of subjects: 22

Group type: COMPARATOR
Intervention: Single-layered vacuum-formed EVA mouthguard
Number of subjects: 22
Study: 12354679

Group type: EXPERIMENTAL
Intervention: Multivitamin-multimineral supplementation (VITALIA-tablets)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 10192755

Group type: EXPERIMENTAL
Intervention: Fluvoxamine 50 mg as a single oral dose
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg as a single oral dose
Number of subjects: 12
Study: 7547520

Group type: EXPERIMENTAL
Intervention: Radical head and neck irradiation
Number of subjects: 26
Study: 2197382

Group type: EXPERIMENTAL
Intervention: Rectal midazolam 0.25 mg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Rectal midazolam 0.35 mg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Rectal midazolam 0.45 mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 6117434

Group type: EXPERIMENTAL
Intervention: Oral ranitidine administration
Number of subjects: 16

Group type: COMPARATOR
Intervention: 1 mg/kg body wt ranitidine infusion
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cimetidine (implied control)
Number of subjects: 16